Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever

Rheumatology International

Volumn 30, Issue 4, 2010, Pages 467-471

  Uyanik, Abdullah ^a   Albayrak, Fatih ^a   Uyanik, M Hamidullah ^a   Dursun, Hakan ^a   Keles, Mustafa ^a   Cetinkaya, Ramazan ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Anti CCP; Arthritis; FMF

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FERRITIN; FIBRINOGEN; RHEUMATOID FACTOR; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; JOINT; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; JOINTS; MALE; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 77949879628     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0993-5     Document Type: Article

References (22)

1. Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659-664. doi:10.1016/S0140-6736(97)09408-7 (Pubitemid 28098460)
2. Özen S (2003) Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr 162:449-454. doi:10.1007/s00431-003- 1223-x (Pubitemid 36904264)
3. Garcia-Gonzalez A, Weisman MH (1992) The arthritis of familial Mediterranean fever. Semin Arthritis Rheum 22:139-150. doi:10.1016/0049-0172(92) 90014-5 (Pubitemid 23007018)
4. Ince E, Çakar N, Tekin M, Kendirli T, Özkaya N, Akar N et al (2002) Arthritis in children with familial Mediterranean fever. Rheumatol Int 21:213-217. doi:10.1007/s00296-001-0168-5 (Pubitemid 34328054)
5. Majeed HA, Rawashdeh M (1997) The clinical patterns of arthritis in children with familial Mediterranean fever. Q J Med 90:37-43
6. Brodey PA, Woff SM (1975) Radiographic hanges in the sacroiliac joints in familial Mediterranean fever. Radiology 114:331-333
7. El-Shanti HE (2001) Familial Mediterranean fever. Saudi Med J 22:104-109
8. van Venrooij WJ, Zendman AJ, Pruijn GJ (2006) Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 6:37-41. doi:10.1016/j.autrev.2006.03.008 (Pubitemid 44716772)
9. Zendman AJ, van Venrooij WJ, Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arhritis. Rheumatology 45:20-25. doi:10.1093/rheumatology/kei111 (Pubitemid 43033869)
10. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879-1885. doi:10.1002/art.1780401023 (Pubitemid 27452541)
11. Riedemann JP, Muñoz S, Kavanaugh A (2005) The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis-a systematic review. Clin Exp Rheumatol 23:69-76
12. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236-243. doi:10.1186/ar93 (Pubitemid 32223739)
13. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089-1093
14. Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ et al (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6:303-308. doi:10.1186/ar1187
15. Choi SW, Lim MK, Shin DH, Park JJ, Shim SC (2005) Diagnostic performance of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 20:473-478 (Pubitemid 40905524)
16. Damián-Abrego GN, Cabiedes J, Cabral AR (2008) Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 17:300-304. doi:10.1177/0961203307087613 (Pubitemid 351655797)
17. Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E et al (2008) Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 35:77-83
18. Koca SS, Akbulut H, Dag S, Artas H, Isik A (2007) Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behçet's disease. Tohoku J Exp Med 213:297-304
19. Bogliolo L, Alpini C, Caporali R, Scirè CA, Moratti R, Montecucco C (2005) Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol 32:511-515 (Pubitemid 40381424)
20. Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N (2005) The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology 44:1056-1060. doi:10.1093/rheumatology/keh686 (Pubitemid 41487183)
21. Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H et al (2007) Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 26:17-23. doi:10.1007/s10067-006-0214-5 (Pubitemid 46020016)
22. Alenius GM, Berglin E, Rantapää Dahlqvist S (2006) Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 65:398-400. doi:10.1136/ard.2005.040998 (Pubitemid 43268233)